Using the therapeutic drug or device that you selected, please discuss the path to market for your product.
- Discuss how reimbursement is envisioned for your product in the US
- Make sure that you consider if the product would be administered in a hospital or via prescription.
- Include a chart or diagram to describe the process.
- Discuss how reimbursement is envisioned in a country outside of the US
- Include a chart or diagram to describe the process
- What kind of additional RWE studies would you consider to support the value proposition of the product
- Select at least one of the studies that you suggest and describe in detail what data would be needed, how it will be conducted, what the results are expected to show and how you would envision leveraging the study to enhance market access
- Rationale and conclusions
Page limit: 8 pages maximum
| Criteria |
| Reimbursement path description All steps mentioned with associated timelines and requirements for US |
| Conclusions Extracting key information, and logically stating the why. |
| Overall Report Professional, well formatted, grammatically correct, sources cited, and methodology described. |
| Reimbursement path description All steps mentioned with associated timelines and requirements for either UK or France |
| RWE studies Logical selection of RWE evidence study with description and selected measures |
